Company news: Daiichi Sankyo, Astellas, Takeda

Share this article:
Japanese pharma giants are taking stock of the damage from last Friday's Tohoku Earthquake and tsunami. Tokyo-based Daiichi Sankyo said all its employees were safe and accounted for, though a few had suffered minor injuries. The company said two plants were partly damaged by the earthquake, and sales and marketing activities at several branches in hard-hit areas had been halted. Astellas, also based in Tokyo, said it had confirmed that all of its and its affiliates' employees were safe, but that operations at two manufacturing plants and a chemistry lab had been halted and marketing employees based in devastated regions instructed to remain on standby at home. Osaka-based Takeda announced it would donate 300 million yen and pharmaceutical products to relief efforts.

The pharmaceutical industry ranked well in The National Association of Female Executives' annual list of the top 50 companies for female executives. Among the companies that made the list were Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, J&J, Merck and Pfizer.
Share this article:

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.